Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$77 | -$67 | -$24 | -$35 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $14 | $5 | $6 |
| Change in WC | $2 | $10 | -$2 | -$1 |
| Other Non-Cash | $5 | $3 | $2 | $1 |
| Operating Cash Flow | -$61 | -$39 | -$19 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$4 | -$69 |
| Inv. Sales/Matur. | $0 | $0 | $59 | $69 |
| Other Inv. Act. | $0 | $0 | -$0 | -$0 |
| Investing Cash Flow | -$0 | -$0 | $54 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | $44 | -$44 | $5 |
| Stock Issued | $40 | $30 | $27 | $28 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | -$0 | $1 |
| Financing Cash Flow | $38 | $74 | -$17 | $34 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23 | $35 | $19 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | $34 | $16 | $11 |
| End Cash | $46 | $70 | $34 | $16 |
| Free Cash Flow | -$61 | -$39 | -$19 | -$28 |